Compound Q&A
What is the market or research trend for ent-Rivaroxaban (CAS: 865479-71-6)?
Answer
The market for ent-Rivaroxaban (CAS: 865479-71-6) continues to grow due to its efficacy in treating deep vein thrombosis and pulmonary embolism. Research trends focus on its potential in cardiology and hematology, as well as its role in cardiovascular risk reduction. Price trends indicate steady demand with slight fluctuations driven by clinical trial outcomes and new therapeutic indications.
About
CAS No
865479-71-6
English Name
ent-Rivaroxaban
Molecular Formula
C19H18ClN3O5S
Molecular Weight
435.88 g/mol
SMILES
O=C1OC(CN1c1ccc(cc1)N1CCOCC1=O)CNC(=O)c1ccc(s1)Cl
InChIKey
KGFYHTZWPPHNLQ-UHFFFAOYSA-N
Last Updated: 2025-10-17 17:23
